OneMedNet (NASDAQ:ONMD) Stock: Insider Robert Lawrence Golden Sells 3,000 Shares

OneMedNet Corporation (NASDAQ:ONMD) CFO Robert Lawrence Golden sold 3,000 shares of the company’s stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $6.63, for a total transaction of $19,890.00. Following the transaction, the chief financial officer owned 91,291 shares in the company, valued at approximately $605,259.33. This trade represents a 3.18% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Lawrence Golden also recently made the following trade(s):

• On Tuesday, September 15th, Robert Lawrence Golden sold 3,000 shares of OneMedNet stock. The shares were sold at an average price of $6.30, for a total value of $18,900.00.

OneMedNet Stock Performance

OneMedNet stock traded down $0.52 during trading hours on Friday, reaching $4.30. 24,653 shares of the company’s stock traded hands, compared to its average volume of 69,105. OneMedNet Corporation has a fifty-two week low of $4.30 and a fifty-two week high of $42.20. The firm’s 50 day moving average is $6.24 and its 200-day moving average is $7.32. The firm has a market capitalization of $25.50 million, a price-to-earnings ratio of -2.69 and a beta of 1.14.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 24th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

About OneMedNet

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.